HealthQuill Pharma
US researchers have identified 275 million unreported genetic variants in a quarter of a million volunteers that may help understand genetic influences on health and diseases.
Drugs Health Pharma

US researchers spot 275m new genetic variants, may help treat diseases

HQ Team February 20, 2024: US researchers have identified 275 million unreported genetic variants in a quarter of a million volunteers that may.

Read More
Pfizer’s Velsipity, an oral drug to treat inflammatory bowel disease, got approval from the European Commission for patients aged 16 and above, according to a company statement.
Drugs Health Pharma

Pfizer Inc’s oral drug for ulcerative colitis gets approval from the EU

HQ Team February 20, 2024: Pfizer’s Velsipity, an oral drug to treat inflammatory bowel disease, got approval from the European Commission for patients.

Read More
About 16% of children or one in six children under two years of age in the Northern Gaza Strip, which has been cut off from aid for weeks, are “acutely malnourished,” according to a WHO report based on data collected in January.
Drugs Health Pharma

Hunger, diseases grip undernourished children, women in Gaza: WHO report

HQ Team February 20, 2024: About 16% of children or one in six children under two years of age in the Northern Gaza.

Read More
allergy
Drugs Health Pharma

FDA approves Genetech’s Xolair injection for severe food allergies

HQ Team February 19, 2024: The Food and Drug Administration (FDA) has approved Genetech’s Xolair (omalizumab) injection for severe food allergies in certain adults.

Read More
Iovance Biotherapeutics, a San Carlos, California-based company, has been given the nod for its T-cell therapy to treat melanoma — the most serious form of skin cancer — in adult patients.
Drugs Health Pharma

New drug to fight skin cancer gets nod from US drug regulator

HQ Team February 17, 2024: Iovance Biotherapeutics, a San Carlos, California-based company, has been given the nod for its T-cell therapy to treat.

Read More
The USFDA has cleared AstraZeneca’s lung cancer drug Tagrisso with chemotherapy for treatment in adult patients.
Drugs Health Pharma

AstraZeneca’s non-small lung cancer therapy gets FDA clearance

HQ Team February 17, 2024: The USFDA has cleared AstraZeneca’s Tagrisso with chemotherapy for treatment in adult patients with non-small cell lung cancer..

Read More
Drugs Health Pharma

US regulator gives green light for first-ever drug for severe frostbite

HQ Team February 16, 2024: The U.S. Food and Drug Administration (FDA) has approved the first-ever drug, iloprost, to treat severe frostbite in.

Read More
Children with the disorder (ASD) have difficulty communicating and interacting with others. They have very narrow interests and spend hours doing repetitive tasks seemingly without purpose.
Drugs Health Pharma

Opinion: Reason yet unclear on what causes autism disorder

By K. Leelamoni February 15, 2024: Autism Spectrum Disorders are a diverse group of conditions related to brain development and characterised by some.

Read More
The US state of Oregon has confirmed its first case of bubonic plague in eight years and authorities say there is no cause for worry with no new cases of the disease being reported.
Drugs Health Pharma

US Oregon state reports first case of bubonic plague in 8 years

HQ Team February 15, 2024: The US state of Oregon has confirmed its first case of bubonic plague in eight years and authorities.

Read More
Drugs Medical Pharma

Gilead buys CymaBay for $ 4.3b to expand its liver portfolio

HQ Team February 13, 2024: Gilead Sciences is buying CymaBay Therapeutics for $4.3 billion, to access its portfolio of drugs for liver and.

Read More